Northwestern Mutual Wealth Management’s Allogene Therapeutics ALLO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08K	Hold	1,000	–	–	﹤0.01%	3640
2026 Q1	$2.44K	Hold	1,000	–	–	﹤0.01%	3542
2025 Q4	$1.37K	Hold	1,000	–	–	﹤0.01%	3572
2025 Q3	$1.24K	Hold	1,000	–	–	﹤0.01%	3499
2025 Q2	$1.13K	Hold	1,000	–	–	﹤0.01%	3367
2025 Q1	$1.46K	Hold	1,000	–	–	﹤0.01%	3218
2024 Q4	$2.13K	Hold	1,000	–	–	﹤0.01%	3164
2024 Q3	$2.8K	Hold	1,000	–	–	﹤0.01%	3044
2024 Q2	$2.33K	Hold	1,000	–	–	﹤0.01%	3065
2024 Q1	$4.47K	Hold	1,000	–	–	﹤0.01%	2873
2023 Q4	$3.21K	Hold	1,000	–	–	﹤0.01%	2982
2023 Q3	$3.17K	Hold	1,000	–	–	﹤0.01%	2865
2023 Q2	$4.97K	Hold	1,000	–	–	﹤0.01%	2789
2023 Q1	$4.94K	Hold	1,000	–	–	﹤0.01%	2752
2022 Q4	$6.29K	Hold	1,000	–	–	﹤0.01%	2657
2022 Q3	$11K	Hold	1,000	–	–	﹤0.01%	2420
2022 Q2	$11K	Hold	1,000	–	–	﹤0.01%	2466
2022 Q1	$9K	Hold	1,000	–	–	﹤0.01%	2559
2021 Q4	$15K	Hold	1,000	–	–	﹤0.01%	2429
2021 Q3	$26K	Buy	+1,000	New	+$23.7K	﹤0.01%	2122

Other funds holding ALLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northwestern Mutual Wealth Management's ALLO Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Allogene Therapeutics (ALLO) position steady in Q2 2026 at 1,000 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3640.

Northwestern Mutual Wealth Management first reported a position in ALLO in Q3 2021 and has held it in 20 quarters since. The position peaked at $26K in Q3 2021. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

Northwestern Mutual Wealth Management held 1,000 shares of Allogene Therapeutics worth $2.08K as of Q2 2026.
Northwestern Mutual Wealth Management left its Allogene Therapeutics share count unchanged in Q2 2026.
Allogene Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3640 holding.
Northwestern Mutual Wealth Management first reported a position in Allogene Therapeutics in Q3 2021 and has held it in 20 quarters since.
Northwestern Mutual Wealth Management's Allogene Therapeutics position peaked at $26K in Q3 2021.
209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.